» Articles » PMID: 33904776

Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening

Overview
Journal Radiology
Specialty Radiology
Date 2021 Apr 27
PMID 33904776
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license

Citing Articles

The Whole-Body MRI Reporting and Data System Guidelines for Prostate Cancer (MET-RADS-P), Multiple Myeloma (MY-RADS), and Cancer Screening (ONCO-RADS).

Parillo M, Mallio C Cancers (Basel). 2025; 17(2).

PMID: 39858056 PMC: 11763526. DOI: 10.3390/cancers17020275.


Characterization of sarcoma topography in Li-Fraumeni syndrome.

Brockman K, Thompson M, Mirabello L, Savage S, Malayeri A, Hatton J Front Oncol. 2024; 14:1415636.

PMID: 39575416 PMC: 11578819. DOI: 10.3389/fonc.2024.1415636.


Feasibility of whole-body MRI for cancer screening in children and young people with ataxia telangiectasia: A mixed methods cross-sectional study.

Neves R, Panek R, Clarkson K, Panagioti O, Fernandez N, Wilne S Cancer Med. 2024; 13(14):e70049.

PMID: 39056567 PMC: 11273546. DOI: 10.1002/cam4.70049.


Whole-body MRI in oncology: acquisition protocols, current guidelines, and beyond.

Zugni F, Mariani L, Lambregts D, Maggioni R, Summers P, Granata V Radiol Med. 2024; 129(9):1352-1368.

PMID: 38990426 DOI: 10.1007/s11547-024-01851-6.


Image quality of whole-body diffusion MR images comparing deep-learning accelerated and conventional sequences.

Ponsiglione A, McGuire W, Petralia G, Fennessy M, Benkert T, Ponsiglione A Eur Radiol. 2024; 34(12):7985-7993.

PMID: 38960946 DOI: 10.1007/s00330-024-10883-5.